Prostate cancer cells overexpress fatty acid synthase protein (FASN) and monoacylglycerol lipase (MAGL), both metabolic enzymes that promote the formation and breakdown of lipids, which are now thought to be metabolic oncogenes [79,80,81]. This evidence concerns the gene MGLL and prostate cancer.